About 20 pharmas including Hanmi Pharm compete in antithrombotic market

As ‘Brilinta Tab(generic name: ticagrelor),’a AstraZeneca’s antithrombotic, is expired in its PMS(Post-Marketing Surveillance), about 20 Korean pharmaceutical companies including Hanmi Pharm jumped into its market after getting generic approval.

According to the Ministry of Food and Drug Safety(MFDS), the PMS of the AstraZeneca Korea’s antithrombotic ‘Brilinta Tab 60mg & 90mg(generic name: tic...